These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 18451705

  • 21. Animal models of multiple sclerosis.
    Furlan R, Cuomo C, Martino G.
    Methods Mol Biol; 2009; 549():157-73. PubMed ID: 19378202
    [Abstract] [Full Text] [Related]

  • 22. Brain-derived neurotrophic factor in neuroimmunology: lessons learned from multiple sclerosis patients and experimental autoimmune encephalomyelitis models.
    Lühder F, Gold R, Flügel A, Linker RA.
    Arch Immunol Ther Exp (Warsz); 2013 Apr; 61(2):95-105. PubMed ID: 23283517
    [Abstract] [Full Text] [Related]

  • 23. [Multiple sclerosis and experimental autoimmune encephalomyelitis].
    Béraud-Juven E.
    Rev Prat; 1994 Jan 01; 44(1):69-74. PubMed ID: 8178062
    [Abstract] [Full Text] [Related]

  • 24. The role of TNF related apoptosis-inducing ligand in neurodegenerative diseases.
    Huang Y, Erdmann N, Peng H, Zhao Y, Zheng J.
    Cell Mol Immunol; 2005 Apr 01; 2(2):113-22. PubMed ID: 16191417
    [Abstract] [Full Text] [Related]

  • 25. Multiple sclerosis: trapped in deadly glue.
    Platten M, Steinman L.
    Nat Med; 2005 Mar 01; 11(3):252-3. PubMed ID: 15746934
    [No Abstract] [Full Text] [Related]

  • 26. The role of adhesion molecules in multiple sclerosis: biology, pathogenesis and therapeutic implications.
    Archelos JJ, Hartung HP.
    Mol Med Today; 1997 Jul 01; 3(7):310-21. PubMed ID: 9257299
    [Abstract] [Full Text] [Related]

  • 27. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).
    Ziemssen T, Ziemssen F.
    Autoimmun Rev; 2005 Sep 01; 4(7):460-7. PubMed ID: 16137612
    [Abstract] [Full Text] [Related]

  • 28. Complement activation in autoimmune demyelination: dual role in neuroinflammation and neuroprotection.
    Rus H, Cudrici C, Niculescu F, Shin ML.
    J Neuroimmunol; 2006 Nov 01; 180(1-2):9-16. PubMed ID: 16905199
    [Abstract] [Full Text] [Related]

  • 29. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis.
    Martin R, McFarland HF.
    Crit Rev Clin Lab Sci; 1995 Nov 01; 32(2):121-82. PubMed ID: 7598789
    [Abstract] [Full Text] [Related]

  • 30. Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications.
    Stadelmann C.
    Curr Opin Neurol; 2011 Jun 01; 24(3):224-9. PubMed ID: 21455066
    [Abstract] [Full Text] [Related]

  • 31. Comparing the CNS morphology and immunobiology of different EAE models in C57BL/6 mice - a step towards understanding the complexity of multiple sclerosis.
    Kuerten S, Angelov DN.
    Ann Anat; 2008 Jun 01; 190(1):1-15. PubMed ID: 18342137
    [Abstract] [Full Text] [Related]

  • 32. Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures.
    Karussis D, Slavin S.
    J Neurol Sci; 2004 Aug 15; 223(1):59-64. PubMed ID: 15261562
    [Abstract] [Full Text] [Related]

  • 33. Macrophages and neurodegeneration.
    Hendriks JJ, Teunissen CE, de Vries HE, Dijkstra CD.
    Brain Res Brain Res Rev; 2005 Apr 15; 48(2):185-95. PubMed ID: 15850657
    [Abstract] [Full Text] [Related]

  • 34. Susceptibility to experimental allergic encephalomyelitis in animal models of autoimmunity.
    Lublin FD.
    Curr Opin Neurol Neurosurg; 1992 Apr 15; 5(2):182-7. PubMed ID: 1377972
    [Abstract] [Full Text] [Related]

  • 35. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
    Friese MA, Fugger L.
    Brain; 2005 Aug 15; 128(Pt 8):1747-63. PubMed ID: 15975943
    [Abstract] [Full Text] [Related]

  • 36. Immunopathogenesis and immunotherapy of multiple sclerosis.
    Hemmer B, Nessler S, Zhou D, Kieseier B, Hartung HP.
    Nat Clin Pract Neurol; 2006 Apr 15; 2(4):201-11. PubMed ID: 16932551
    [Abstract] [Full Text] [Related]

  • 37. Neurodegeneration in multiple sclerosis: novel treatment strategies.
    Luessi F, Siffrin V, Zipp F.
    Expert Rev Neurother; 2012 Sep 15; 12(9):1061-76; quiz 1077. PubMed ID: 23039386
    [Abstract] [Full Text] [Related]

  • 38. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).
    Moore CS, Hebb AL, Blanchard MM, Crocker CE, Liston P, Korneluk RG, Robertson GS.
    J Neuroimmunol; 2008 Oct 15; 203(1):79-93. PubMed ID: 18687476
    [Abstract] [Full Text] [Related]

  • 39. [Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis].
    Rodríguez-Rodríguez Y, Suárez-Luis I.
    Rev Neurol; 2008 Oct 15; 36(7):649-52. PubMed ID: 12666047
    [Abstract] [Full Text] [Related]

  • 40. Immunological basis for the development of tissue inflammation and organ-specific autoimmunity in animal models of multiple sclerosis.
    Korn T, Mitsdoerffer M, Kuchroo VK.
    Results Probl Cell Differ; 2010 Oct 15; 51():43-74. PubMed ID: 19513635
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.